UK Authorizes ‘Gamechanger’ AstraZeneca Vaccine Despite Data Doubts

MHRA Rejects Low Dose Data

 
• By Andrew McConaghie

UK regulator admits evidence sparse on older patients, but believes longer gap between doses can boost efficacy and accelerate numbers of people immunized.

UK COVID Tier 4
Infection rate in England is being driven up by the new COVID-19 variant • Source: Shutterstock

More from Vaccines

More from Pink Sheet